In select cases, probiotics may be incorporated into a routine to support digestive comfort as the gut adapts to new intake patterns, though individual response can vary
Proc Natl Acad Sci USA
Lafferty RA, Flatt PR, Irwin N (2023) GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPERORreduced and DAPA-HF trials
The system may require patient identity verification, provider information confirmation, and electronic consent and signatures
280 The current challenges and costs of GLP-1 therapy highlight the urgent need for rigorous research on how staged or combination nutritional programs, including multiple components and possibly FIM therapies, might improve outcomes, mitigate weight regain or cycling, and promote health equity